Abenacianine, a fluorescent imaging agent, aids in real-time tumor visualization during lung cancer surgeries, enhancing surgical precision and outcomes. Fast track designation by the FDA highlights ...
The Fast Track designation is supported by the ongoing randomized, double-masked phase 3 LYNX-2 trial. The Food and Drug Administration (FDA) has granted Fast Track designation to phentolamine ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback